Disclosure 0001649904-26-000023-2

SEC FORM 4

$2,413,033.57

RHYTHM PHARMACEUTICALS, INC. (RYTM)

Sale of 23,072 shares at $104.5871 per share.

Reporting Person Smith Hunter C · Officer Title Chief Financial Officer · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001649904-26-000023 · filed 2026-09-01 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "RHYTHM PHARMACEUTICALS, INC. (RYTM)." Disclosed 2026-09-01. https://desqlong.com/cards/0001649904-26-000023-2 (retrieved 2026-09-26).